The Cytoskeleton as a Pharmacological Target in Neurodegenerative Diseases
Author:
Oz Saar,Gozes Iliana
Reference108 articles.
1. Flament-Durand J, Couck AM (1979) Spongiform alterations in brain biopsies of presenile dementia. Acta Neuropathol 46:159–162 2. Ellisman M, Ranganathan R, Deerinck T, Young S, Terry R, Mirra S (1987) Neuronal fibrillar cytoskeleton and endomembrane system organization in Alzheimer’s disease. Adv Behav Biol. 34:61–75; Plenum Press, New York, NY 3. Terry RD (1998) The cytoskeleton in Alzheimer disease. J Neural Transm Suppl 53:141–145 4. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G (2003) Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation. Am J Pathol 162:1623–1627 5. Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, Yamaguchi H, Takashima A (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22:133–141
|
|